Skip to main content

Find Clinical Trials

Home
Conditions
Fallopian Tube Cancer

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

335 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Completed

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

NCT00032162

Conditions: Adnexal Diseases, Cervical Cancer, Endocrine Gland Neoplasms, +26 more
Locations: Universitaetsklinikum Charite Berlin, Germany

Zentralkrankenhaus Bremen, Germany

Medizinische Klinik I Dresden, Germany

Universitaetsklinik Duesseldorf Düsseldorf, Germany

View all 19 locations

View Trial Details

Completed

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00004060

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

NCT00245050

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +34 more
Locations: Geauga Regional Hospital Cleveland, Ohio, United States

Lake/University Ireland Cancer Center Cleveland, Ohio, United States

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Southwest General Health Center Cleveland, Ohio, United States

View Trial Details

Completed

Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer

NCT00466986

Conditions: Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +21 more
Locations: Southeastern Gynecologic Oncology Atlanta, Georgia, United States

View Trial Details

Completed

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Precision Therapeutics, Inc. Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00028912

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00006391

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

View Trial Details

Completed

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

NCT00517621

Conditions: Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +26 more
Locations: HOTEL DIEU Hospital Paris, France

View Trial Details

Completed

Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse

NCT00189566

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Hôpital Hotel Dieu Paris, France

View Trial Details

Completed

Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT00217555

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: University of Washington School of Medicine Seattle, Washington, United States

View Trial Details